gallinamide-a and Melanoma

gallinamide-a has been researched along with Melanoma* in 1 studies

Other Studies

1 other study(ies) available for gallinamide-a and Melanoma

Article	Year
A novel Anti-Cancer Stem Cells compound optimized from the natural symplostatin 4 scaffold inhibits Wnt/β-catenin signaling pathway. European journal of medicinal chemistry, 2018, Aug-05, Volume: 156 Topics: Animals; Antimicrobial Cationic Peptides; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Discovery; Humans; Melanoma; Melanoma, Experimental; Mice, Inbred C57BL; Neoplasm Invasiveness; Neoplastic Stem Cells; Peptides; Wnt Signaling Pathway	2018

Article

Year

A novel Anti-Cancer Stem Cells compound optimized from the natural symplostatin 4 scaffold inhibits Wnt/β-catenin signaling pathway.

European journal of medicinal chemistry, 2018, Aug-05, Volume: 156

Topics: Animals; Antimicrobial Cationic Peptides; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Discovery; Humans; Melanoma; Melanoma, Experimental; Mice, Inbred C57BL; Neoplasm Invasiveness; Neoplastic Stem Cells; Peptides; Wnt Signaling Pathway

2018